Bacterial infections in burn patients at a burn hospital in Iran.
Methods: During the one year period (May 2003 to April 2004), 182 patients were included in this study. Blood, urine and wound biopsy samples were taken 7 and 14 days after admission to Taleghani Burn hospital. Isolation and identification of microorganisms was done using the standard procedure. Disk diffusion test were performed for all the isolates for antimicrobial susceptibility.
Results: Of the 182 patients, 140 (76.9%) acquired at least one type of infection of the 140, 116 patients (82.8%) were culture positive on day 7 while 24 (17.2%) on 14 days after admission. Primary wound infection was most common (72.5%), followed by blood stream (18.6%) and urinary tract infections (8.9%).
The microorganisms causing infections were Pseudomonas aeruginosa (37.5%), Staphylococcus aureus (20.2%), and Acinetobacter baumanni (10.4%). Among these isolates P. aeruginosa was found to be 100 per cent resistant to amikacin, gentamicin, carbeniciilin, ciprofloxacin, tobramycin and ceftazidime; 58 per cent of S. aureus and 60 per cent of coagulase negative Staphylococcus were methicillin resistant.
Interpretation & conclusions: High prevalence of nosocomial infections and the presence of multidrug resistant bacteria, and methicillin resistant S. aureus in patients at Taleghani Burn Hospital suggest continuous surveillance of burn infections and develop strategies for antimicrobial resistance control and treatment of infectious complications.
Key words Antimicrobial resistance--burn wounds--nosocomial infection
In spite of considerable advances in the treatment of burns, infection continues to pose the greatest danger to burn patients. Approximately 73 per cent of all death within the first five days post-burn have been shown to be directly or indirectly caused by septic processes (1). Different patient groups such as burn patients and trauma patients have unique predisposition to different infections. In a Swedish study (2), the most common infection was burn wound infection (60%) followed by blood stream infection (20%), urinary tract infection (20%), and pneumonia (10%). This distribution of infections is strikingly different from the study by Wurtz et al (3) in which over 50 per cent of infections were pneumonia followed by urinary tract infection, blood stream infection and wound infection.
The common pathogens isolated from burn patients include Pseudomonas aeruginosa, Staphylococcus aureus, Klebsillea spp, and various coliform bacilli. Fungi (Candida albicans, Aspergillus fumigatus) can also cause infection (4-8). Multidrug-resistant bacteria have frequently been reported as the cause of nosocomial outbreaks of infection in burn units or as colonizers of the wounds of burn patients (9,10). Similarly, antimicrobial resistance in some of the most frequent bacterial species isolated from burn patients in Iran such as S. aureus or P. aeruginosa, and other Gram negative bacilli has reached to a worrying level (11,12). Based on National Nosocomial Infection Surveillance System (NNIS) criteria, all the burn patients are required to follow the distribution of bacterial species among burn isolates, and the antimicrobial susceptibility of the pathogens in order to adapt empirical antibiotic strategies (13). This study was carried out to determine three types of nosocomial infections viz., burn wound infection, urinary tract infection, and blood stream infection caused by bacterial pathogens isolated from burned patients at Taleghani Burn Hospital in Khuzestan province, Ahvaz, Iran as also the susceptibility of these isolates to various antibiotics.
Material & Methods
A total of 182 patients were admitted to the Taleghani Burn Hospital which is an academic educational hospital affiliated to Ahvaz Jundi-Shapour University of Medical Sciences during the one year period (from May 2003 to April 2004). This hospital is the only referral centre for Khuzestan province, Iran.
None of the patients included in the study had any sign and symptoms of urinary tract infection (UTI), blood stream infection (BSI), and wound infection (WI) based on NNIS system criteria (13) within the first 48 h after the admission.
Blood, urine and wound biopsy samples were taken on day 7 and 14 after admission, and then cultured on blood agar and MacConkey agar. Isolation and identification of microorganisms was done according to standard procedure (14).
Disk diffusion test were performed for all the isolates by the method recommended by Clinical and Laboratory Standard Institute (CLST) (15). A suspension of each isolate was made so that the turbidity was equal to 0.5 McFarland standard and then plated onto Muller-Hinton agar (Difcos) plate. Antibiotic disk (Oxoid) was applied to each plate (Table). After incubation at 35[degrees]C for 24 h, zone size was measured. Reference strains included were ATCC 25923 (S. aureus) and ATCC 35218 (Escherichia coli), obtained from Jundishapour University of Medical Sciences, Ahvaz, Iran. The analysis of the data was performed with the SPSS 10 (SPSS inc, Chicago, IL). This work was approved by the Ethical Committee of the Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.
The mean age of patients was 19.3 [+ or -] 17.05 yr (< 1-70 yr). There were 108 males (59.3 %) and 74 females (40.6%) with a male to female ratio 1.45:1.
Culture positivity on 7 and 14 days after admission was seen in 116 (82.8%) and 24 (17.2%) patients, respectively. Of the 182 patients, 140 (77.3%) suffered at least one type of nosocomial infection (UTI, BSI and WI). The wound infection was the most frequent (76.9%), followed by blood infection (18.6%) and urinary tract infection (8.9%).
A total of 173 bacterial isolates were obtained. The most predominant bacterial isolate was Pseudomonas aeruginosa 65 (37.5%) followed by Staphylococcus aureus 35 (20.2%), Acinetobacter baummanni 18 (10.4%), Escherichia coli 10 (5.7%), Proteus mirabilis 9 (5.2%), coagulase negative Staphylococus 9 (5.2%), Enterobacter aerogenes 9 (5.2%), Klebsiella pneumoniae 6 (3.4%), Enterococcus spp. 4 (2.3%), Citrobacter freundii 3(1.7%), Serratia marcescens 2 (1.1%), Alcaligenes spp. 2(1.1), [beta] haemolytic group A Streptococcus 1(0.5%).
It is worth to note that 58 per cent of S. aureus and 60 per cent of coagulase negative Staphylococcus were methicillin resistant. However, these isolates were susceptible to vancomycin and teicoplanin. P. aeruginosa was resistant to gentamicin, cephalothin, ciprofloxacin, amikacin, carbenicilin, ceftazidime, tobramycin (100%) and cephalexin (98) respectively (Table).
Despite significant improvement in the survival of burn patients, infectious complications continue to be the major cause of morbidity and mortality (16). Though control of invasive bacterial burn wound infection, strict isolation techniques and infection control policies have significantly minimized the occurrence of burn wound infection (17), our study showed high prevalence of bacterial infections among burn patients as compared to another study from Iran (18).
Our study indicated that the wound infection was the most common cause of nosocomial infection. Rastegar et al (11) at Tohid Burn Center in Tehran, Iran, reported the same. Askarian et al (18) also reported the wound infection as the most common cause of nosocomial infection was followed by BSI and UTI.
Our study showed P. aeruginosa as a common cause of nosocomial infection, similar to our earlier study (16). Other studies also showed that nosocomial infection caused by P. aeruginosa was the major danger in burn patients in Iran (11,12).
In our study 58 per cent of S. aureus MRSA were methicillin resistant. This pathogen has been reported as a major cause of nosocomial infection in Europe (19,20).
To conclude, burn patients were most commonly infected with P. aeruginosa and S. aureus and they were resistant of most of the antibiotics tested. A nosocomial infection surveillance system may be introduced to reduce the rate of nosocomial infections among burn patients, and for better therapeutic options.
Authors acknowledge Ahvaz Jundi-Shapour University of Medical Sciences, Ahvaz, Iran, for financial support.
Received January 24, 2007
(1.) Tancheva D, Hadjiiski O. Effect to early nutritional support on clinical course and septic complications in patients with severe bums. Ann Burns Fire Disasters 2005; 18 : 74-9.
(2.) Appelgren P. Bjornhagen V, Bragderyd K. A prospective study of infections in burn patients. Burns 2002; 28 : 39-46.
(3.) Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nosocomial infections in a burn intensive care unit. Burns 1995; 21 : 181-4.
(4.) Revathi G, Puria J, Jaid K. Bacteriology of bums. Burns 1998; 24 : 347-9.
(5.) Skoll PJ, Hudson DA, Simpson JA. Aeromonas hydrophila in burn patients. Burns 1998; 24 : 350-3.
(6.) Lawrence J. Burn bacteriology during the past 50 years. Burns 1994; 18 : 23-9.
(7.) Nudegusio L, Algimantas T, Rytis R, Minmdaugas K. Analysis of burn patients and the isolated pathogens. Lithuanian Surg 2004; 2 : 190-3.
(8.) Shahid M, Malik A. Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients. Indian J Med Res 2005; 122 ; 324-9.
(9.) Karlowsky JA, Jones ME, Draghi DC, Thomsberry C, Sahm DF, Volturo GA. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob 2004; 3 : 3-7.
(10.) Agnihotri N, Gupta V, Joshi RM. Aerobic bacterial isolates from burn wound infections and their antibiograms-a five-year study. Burns 2004; 30 : 241-3.
(11.) Rastegar A, Alaghehbandan R, Akhlaghi L. Burn wound infection and antimicrobial resistance in Tehran, Iran: An increasing problem. Ann Burn Fire Disasters 2005; 18 : 11158.
(12.) Rastegar A, Bahrami H, Alaghehbandan R. Pseudomonas infection in Tohid burn centre, Iran. Burns 1998; 24 : 637-41.
(13.) Garner J, Jarvis W, Emori T. CDC definition for nosocomial infections. Am J Infect Control 1988; 16 : 128-40.
(14.) Baron J, Finglod S. Methods for identification of ethiologic agents of infections diseases. In : Baliy & Scott's diagnostic microbiology. 10th ed. St. Louis, USA: Mosby, Inc; 1996. p. 327-529.
(15.) Clinical and Laboratory Standard Institute. Performance standards for antimicrobial disk susceptibility tests. NCCLS documents M 100 S15. Wayne, PA, USA: Clinical and Laboratory Standard Institute; 2005.
(16.) David W, Albert T, Basil A. Infection of burn wounds. In: Bennett J, Brachman P, Hospital Infections, 4th ed. Philadelphia: Lippincott--Raven; 1998. p. 587-601.
(17.) Amin M, Kalantar E. Bacteriological monitoring of hospital borne septicemia in burn patients in Ahvaz , Iran. Burn Surgical Wound Care 2004; 3 : 4-8.
(18.) Askarian M, Hossseini R. Incidence and outcome of nosocomial infections in female bum patients in Shiraz, Iran. Am J Infect Control 2004; 32 : 25-8.
(19.) EARSS management team. Susceptibility of S. aureus. EARSS Newslett 2002; 4 : 4-5.
(20.) Wildemauee C, Godard C, Vershragen G, Claeys G, Duyck C, De Beenhouwer H. Ten years phage typing of Belgian Clinical methicillin-resistant S. aureus isolates. J Hosp Infect 2004; 56 : 16-21.
Reprint requests: Dr Kalantar E, Department of Microbiology, School of Medicine, Kurdestan University of Medical Sciences Kurdestan, Iran e-mail: email@example.com; firstname.lastname@example.org
Alireza Ekrami & Enayat Kalantar *
Department of Laboratory Medical Sciences, School of Paramedical Sciences, Ahvaz Jundi-Shapour University of Medical Sciences, Ahvaz & * Department of Microbiology, School of Medicine, Kurdestan University of Medical Sciences, Sanandaj, Iran
Table. Antibiotic susceptibility pattern (%) of patients isolates in burn Antibiotic Organism (s) Concentration/ S. aureus Enterobac- P. aeru- disk ([micro]/1) teriaceae ginosa Gentamicin 10 73.3 70 100 Cephalothin 30 73.3 28.5 100 Ciprofloxacin 5 73.3 19 100 Cephalexin 30 74 95 98 Clindamycin 02 75 ND ND Oxacillin 01 58 ND ND Vancomycin 30 0.0 ND ND Amikacin 30 ND 42.3 100 Ampicillin 10 95 100 ND Carbenicillin 100 ND 42 100 Cotrimoxazol 1.25/23.75 89 38 ND Ceftazidine 30 75 55 100 Tobramycin 10 ND 65 100 Antibiotic Organism (s) A. bau- manni Gentamicin 100 Cephalothin 100 Ciprofloxacin 85 Cephalexin 90 Clindamycin ND Oxacillin ND Vancomycin ND Amikacin 100 Ampicillin ND Carbenicillin 100 Cotrimoxazol ND Ceftazidine 100 Tobramycin 70 ND: not done
|Printer friendly Cite/link Email Feedback|
|Author:||Ekrami, Alireza; Kalantar, Enayat|
|Publication:||Indian Journal of Medical Research|
|Article Type:||Case study|
|Date:||Dec 1, 2007|
|Previous Article:||Molecular characterization of chikungunya virus from Andhra Pradesh, India & phylogenetic relationship with Central African isolates.|
|Next Article:||Bacteriological & epidemiological characteristics of diphtheria cases in & around Delhi--a retrospective study.|